Montag A & Associates Inc. Has $7.10 Million Stake in Danaher Co. (NYSE:DHR)

Montag A & Associates Inc. raised its position in shares of Danaher Co. (NYSE:DHR) by 6.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,375 shares of the conglomerate’s stock after purchasing an additional 1,652 shares during the quarter. Montag A & Associates Inc.’s holdings in Danaher were worth $7,097,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of DHR. Cape Investment Advisory Inc. purchased a new stake in Danaher in the 4th quarter worth about $25,000. Tsfg LLC boosted its holdings in shares of Danaher by 733.3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares during the period. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher in the 2nd quarter valued at approximately $25,000. nVerses Capital LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $25,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in shares of Danaher during the 1st quarter valued at $30,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In related news, CEO Rainer Blair sold 9,007 shares of Danaher stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the completion of the sale, the chief executive officer now directly owns 97,983 shares of the company’s stock, valued at $27,435,240. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Rainer Blair sold 9,007 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the completion of the sale, the chief executive officer now owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,659 shares of company stock valued at $11,042,433. 11.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on DHR shares. The Goldman Sachs Group increased their price objective on Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. Royal Bank of Canada increased their price target on shares of Danaher from $297.00 to $300.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Jefferies Financial Group started coverage on Danaher in a report on Monday, June 3rd. They issued a “buy” rating and a $295.00 target price for the company. Leerink Partners lifted their target price on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. Seven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $278.94.

Danaher Trading Up 0.9 %

Shares of NYSE DHR traded up $2.29 during midday trading on Friday, hitting $269.31. The stock had a trading volume of 4,600,180 shares, compared to its average volume of 1,915,256. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The firm has a market cap of $194.50 billion, a P/E ratio of 45.65, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company’s 50-day simple moving average is $260.05 and its 200 day simple moving average is $255.19.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the company posted $2.05 EPS. The company’s revenue was down 2.9% compared to the same quarter last year. Research analysts anticipate that Danaher Co. will post 7.59 EPS for the current year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.